Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Positive t(8;21) Acute Myeloid Leukemia
CONCLUSIONS Allo-HSCT improved the survival of EMI-positive t(8;21) AML.PMID:38111188 | DOI:10.12659/AOT.942197 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 19, 2023 Category: Transplant Surgery Authors: Xiaokai Wang Xuetong Xu Hao Zhang Wei Zhou Dan Gong Chengying Zhu Dejun Zhou Guofeng Chen Source Type: research
Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Positive t(8;21) Acute Myeloid Leukemia
CONCLUSIONS Allo-HSCT improved the survival of EMI-positive t(8;21) AML.PMID:38111188 | DOI:10.12659/AOT.942197 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 19, 2023 Category: Transplant Surgery Authors: Xiaokai Wang Xuetong Xu Hao Zhang Wei Zhou Dan Gong Chengying Zhu Dejun Zhou Guofeng Chen Source Type: research
Allogeneic Hematopoietic Stem Cell Transplantation Can Improve Prognosis of Extramedullary Infiltration Positive t(8;21) Acute Myeloid Leukemia
CONCLUSIONS Allo-HSCT improved the survival of EMI-positive t(8;21) AML.PMID:38111188 | DOI:10.12659/AOT.942197 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 19, 2023 Category: Transplant Surgery Authors: Xiaokai Wang Xuetong Xu Hao Zhang Wei Zhou Dan Gong Chengying Zhu Dejun Zhou Guofeng Chen Source Type: research
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
CONCLUSIONS Rituximab desensitization for LT patients with pDSA was managed successfully without significant complications. Due to the small sample size, we could not demonstrate the benefit of rituximab desensitization for LT patients compared with the rituximab (-) group. Additionally, clinical outcomes in patients with pDSA, with or without rituximab, were similar to those without pDSA. Rituximab desensitization might be not essential for LT.PMID:38098225 | DOI:10.12659/AOT.941456 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 15, 2023 Category: Transplant Surgery Authors: Masato Shizuku Nobuhiko Kurata Kanta Jobara Yasuhiro Fujimoto Yasuhiro Ogura Source Type: research
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
CONCLUSIONS Rituximab desensitization for LT patients with pDSA was managed successfully without significant complications. Due to the small sample size, we could not demonstrate the benefit of rituximab desensitization for LT patients compared with the rituximab (-) group. Additionally, clinical outcomes in patients with pDSA, with or without rituximab, were similar to those without pDSA. Rituximab desensitization might be not essential for LT.PMID:38098225 | DOI:10.12659/AOT.941456 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 15, 2023 Category: Transplant Surgery Authors: Masato Shizuku Nobuhiko Kurata Kanta Jobara Yasuhiro Fujimoto Yasuhiro Ogura Source Type: research
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
CONCLUSIONS Rituximab desensitization for LT patients with pDSA was managed successfully without significant complications. Due to the small sample size, we could not demonstrate the benefit of rituximab desensitization for LT patients compared with the rituximab (-) group. Additionally, clinical outcomes in patients with pDSA, with or without rituximab, were similar to those without pDSA. Rituximab desensitization might be not essential for LT.PMID:38098225 | DOI:10.12659/AOT.941456 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 15, 2023 Category: Transplant Surgery Authors: Masato Shizuku Nobuhiko Kurata Kanta Jobara Yasuhiro Fujimoto Yasuhiro Ogura Source Type: research
Clinical Outcomes of Administration of Rituximab for Desensitization in Liver Transplant Patients with Preformed Donor-Specific Antibodies: A Single-Center Experience
CONCLUSIONS Rituximab desensitization for LT patients with pDSA was managed successfully without significant complications. Due to the small sample size, we could not demonstrate the benefit of rituximab desensitization for LT patients compared with the rituximab (-) group. Additionally, clinical outcomes in patients with pDSA, with or without rituximab, were similar to those without pDSA. Rituximab desensitization might be not essential for LT.PMID:38098225 | DOI:10.12659/AOT.941456 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 15, 2023 Category: Transplant Surgery Authors: Masato Shizuku Nobuhiko Kurata Kanta Jobara Yasuhiro Fujimoto Yasuhiro Ogura Source Type: research
Short-Term Monitoring of Graft Regeneration in Partial Liver Transplantation Recipients
CONCLUSIONS The combination of decreased counts of WBC, neutrophils, lymphocytes, and platelets, as well as elevated PT and APTT on Day 3 after LT showed a good capability to predict a higher rate of liver regeneration after partial liver transplantation.PMID:38083825 | DOI:10.12659/AOT.941444 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 12, 2023 Category: Transplant Surgery Authors: Yuying Shan Xi Yu Yuhao Du Jiongze Fang Jing Huang Jiangnan Sun Yong Yang Shuqi Mao Shengdong Wu Caide Lu Source Type: research
Short-Term Monitoring of Graft Regeneration in Partial Liver Transplantation Recipients
CONCLUSIONS The combination of decreased counts of WBC, neutrophils, lymphocytes, and platelets, as well as elevated PT and APTT on Day 3 after LT showed a good capability to predict a higher rate of liver regeneration after partial liver transplantation.PMID:38083825 | DOI:10.12659/AOT.941444 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 12, 2023 Category: Transplant Surgery Authors: Yuying Shan Xi Yu Yuhao Du Jiongze Fang Jing Huang Jiangnan Sun Yong Yang Shuqi Mao Shengdong Wu Caide Lu Source Type: research
Short-Term Monitoring of Graft Regeneration in Partial Liver Transplantation Recipients
CONCLUSIONS The combination of decreased counts of WBC, neutrophils, lymphocytes, and platelets, as well as elevated PT and APTT on Day 3 after LT showed a good capability to predict a higher rate of liver regeneration after partial liver transplantation.PMID:38083825 | DOI:10.12659/AOT.941444 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 12, 2023 Category: Transplant Surgery Authors: Yuying Shan Xi Yu Yuhao Du Jiongze Fang Jing Huang Jiangnan Sun Yong Yang Shuqi Mao Shengdong Wu Caide Lu Source Type: research
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
CONCLUSIONS In conclusion, our integrated analysis of the case series and the OPTN registry demonstrated promising survival outcomes for patients with refractory bilateral lung cancer who underwent DLT. Although there are limitations to consider, the results of this study underscore the potential benefits of DLT in managing refractory lung-limited lung cancer.PMID:38050347 | PMC:PMC10709990 | DOI:10.12659/AOT.941301 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 5, 2023 Category: Transplant Surgery Authors: Jeeyeon Lee Maria Jose Aguilera Chuchuca Jisang Yu Liam Il-Young Chung Ankit Bharat Young Kwang Chae Source Type: research
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
CONCLUSIONS In conclusion, our integrated analysis of the case series and the OPTN registry demonstrated promising survival outcomes for patients with refractory bilateral lung cancer who underwent DLT. Although there are limitations to consider, the results of this study underscore the potential benefits of DLT in managing refractory lung-limited lung cancer.PMID:38050347 | PMC:PMC10709990 | DOI:10.12659/AOT.941301 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 5, 2023 Category: Transplant Surgery Authors: Jeeyeon Lee Maria Jose Aguilera Chuchuca Jisang Yu Liam Il-Young Chung Ankit Bharat Young Kwang Chae Source Type: research
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
CONCLUSIONS In conclusion, our integrated analysis of the case series and the OPTN registry demonstrated promising survival outcomes for patients with refractory bilateral lung cancer who underwent DLT. Although there are limitations to consider, the results of this study underscore the potential benefits of DLT in managing refractory lung-limited lung cancer.PMID:38050347 | DOI:10.12659/AOT.941301 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 5, 2023 Category: Transplant Surgery Authors: Jeeyeon Lee Maria Jose Aguilera Chuchuca Jisang Yu Liam Il-Young Chung Ankit Bharat Young Kwang Chae Source Type: research
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
CONCLUSIONS In conclusion, our integrated analysis of the case series and the OPTN registry demonstrated promising survival outcomes for patients with refractory bilateral lung cancer who underwent DLT. Although there are limitations to consider, the results of this study underscore the potential benefits of DLT in managing refractory lung-limited lung cancer.PMID:38050347 | DOI:10.12659/AOT.941301 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 5, 2023 Category: Transplant Surgery Authors: Jeeyeon Lee Maria Jose Aguilera Chuchuca Jisang Yu Liam Il-Young Chung Ankit Bharat Young Kwang Chae Source Type: research
Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer
CONCLUSIONS In conclusion, our integrated analysis of the case series and the OPTN registry demonstrated promising survival outcomes for patients with refractory bilateral lung cancer who underwent DLT. Although there are limitations to consider, the results of this study underscore the potential benefits of DLT in managing refractory lung-limited lung cancer.PMID:38050347 | DOI:10.12659/AOT.941301 (Source: Annals of Transplantation)
Source: Annals of Transplantation - December 5, 2023 Category: Transplant Surgery Authors: Jeeyeon Lee Maria Jose Aguilera Chuchuca Jisang Yu Liam Il-Young Chung Ankit Bharat Young Kwang Chae Source Type: research
